Ariadne Australia Limited (ARA) News

CNK
Cinemark upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst David Karnovsky upgraded Cinemark to Overweight from Neutral with a price target of $34, up from $30. The analyst has "increasing visibility and confidence" on 2026 and 2027 supply growth following CinemaC

good morning 😎😎😎😎😎😎😎😎😎😎😎😎

but taking some out before the collapse and then buying back slowly after the collapse works too. It took the NASDAQ ~15 years to get back to its peak in 2000.

Both true. I'd assume that many investors who buy NASDAQ stocks have learned to cash in their "winners" if they have watched

Barchart opinion now says IBATF is a 24% BUY today...The 3rd resistance pt. is .4290 ..Moving in a positive current trend..Need Court case results and some good news.Hold for the gold..Hope this new CEO Mills produces more that Iris Jancik..

Don't assume so much - not good biotech investment strategy!

Thanks for reproducing it; the neckline was briefly broken yet it reversed back up again and with it ending a 5 wave bottoming pattern. As mentioned, keep your eye on the ball and New York Trading (not pre or after market trading)....

In re: Stringtown grocery

Tis a pity that prolly nun of my iHub reedurs will ever visit the Stringtown grocery store. If somehow you find yourself driving on I-80 just a tiny bit west of Iowa City, do make the trek to Stringtown grocery and a bit further to the charming Amish town of

Security details updated yesterday evening on OTCMARKETS.com 
no changes folks!!! I'll be adding first thing this morning before sub .0050s are gone for good 

First week of May brings updates?

HEPA up 13% on play

More shares are coming to the markets now

All good points. Every investor needs to evaluate risk and hopefully understand their financial requirements at every stage in life. I'd hope that retirees would have a balanced portfolio (with a cash component) that would reduce risk and take into account current market conditions, and the potent

Having researched this more, I believe it is not worth "having on our radar".

🔍 Patent WO2025/072823 and the AdHER2 Dendritic Cell Vaccine: A Consolidated Assessment
📘 What the Patent Covers
WO2025/072823, filed by the U.S. Department of Health and Human

Just INCREDIBLE - $STSS .032 up 66% on 100 million shares VOLUME in the early premarket!

Note; when my customers start cancelling orders, WATCH OUT BELOW!

Nice day

You're waking up! 

Lmao RGBP IS DOWN 90% in the last year!!! Cmon man 

Could you or whoever maybe imagine that sometimes you can actually learn something when having a conversation ?
Put it differently, can you imagine that ‘failure’ isn’t always the opposite of success—it’s a stepping stone toward it? I know these are just words, but I do believe in the force

Something about WAMU – Summary:

In the LIBOR case, there were about 20 companies involved in the fraud.

If, in the WAMU case, the key decision-makers (like JPMorgan or the FDIC) were attempting fraud, they would have to deceive not just a handful—but 6,800 companies.

Yet  whatever you say
Whenever you say it
Whatever' you think
Every Friday is
Another week another webs burger post....

RGBP was / is another typical otc scam the last I followed anything on it. Don't remember any meaningful "major" partnership or anything else that benefited shareholders there. Followed that one while I was in ENZC. Must be just like ENZC's "Samsung bio" partnership that literally was a nothing burg

Something about WAMU Part II: In 2012, there was the vote on the POR7, and there was also a document listing the companies/individuals who voted on it. The document can be found here:
https://www.veritaglobal.net/document/0812229120326000000000003

Now that it's 2025 – and Chat

$STSS up 70% to .03 in-premarket-on-80-MILLION-shares-VOLUME!